In summary, we detected a significant association of the MnlI polymorphism in our ADHD sample. Owing to our modest sample size, further investigation by other groups is required to confirm our findings. Especially, whether the ADHD patients with no co-morbid disorders are specifically associated with this SNP warrants further replication in independent samples. This study is also, to our knowledge, the first report on the association of SNAP-25 with ADHD in the East Asian population.
No preferential transmission of paternal alleles at risk genes in attention-deficit hyperactivity disorder Attention-deficit hyperactivity disorder (ADHD) is a heterogeneous neurodevelopmental condition for which a significant genetic component has been suggested, although the mode of inheritance appears to be complex. Recently, Hawi et al. 1 reported data supporting the presence of parent-of-origin effects for the transmission of risk alleles for nine dopaminergic and serotoninergic genes showing association with ADHD. After conducting a transmission/disequilibrium test (TDT) analysis, Hawi and colleagues observed an enhancement of the association findings when parental transmissions were analyzed separately, with association due principally to paternal overtransmission of risk alleles.
To verify this hypothesis, we undertook the investigation of parent-of-origin effects in an independent sample of nuclear families from the Toronto area. The characteristics of the sample, methods of assessment and inclusion/exclusion criteria have been described previously. 2, 3 The number of families genotyped for each gene varied between 142 and 266 families for the different markers, dependent on the stage of family collection at the time of genotyping. We included in our analysis the genes for DAT1, DRD4, DRD5, SNAP25 and 5HT1B, since they are the most replicated genes associated with ADHD and were also tested in Hawi et al.'s study. 1 For DAT1, SNAP25 and DRD5, the most significant variant in our sample was different from those previously reported by others; thus, we also included the marker/allele yielding the best P-value in our sample for these genes. Association results for these five genes using the Toronto sample have been reported fully or partially previously. [4] [5] [6] [7] [8] Note that the DRD4-616 genotyping assay was redesigned and the marker reanalyzed since our original study to avoid interference in the interpretation of the results from a second polymorphism at À615. Similar to Hawi et al., we also show the results from analysis of five additional genes that demonstrated significant evidence of association in the ADHD sample from Toronto. These were the genes for dopamine receptor D1 (DRD1), 9 D1-interacting protein calcyon (DRD1IP), 2 a-subunit of the G s -like protein G olf (GNAL) (Laurin et al. 10 ), glutamate receptor 2B (GRIN2B) (Dorval et al.
11
) and serotonin receptor 2A (HTR2A). 3 We performed a TDT analysis and analyzed transmission from mothers and fathers separately to detect any bias in parental transmission. These analyses were carried out using the extended TDT program. Table 1 shows the TDT analysis results for the total transmissions and for paternal and maternal transmissions separately. In contrast to Hawi et al.'s report, 1 no clear pattern of transmission of risk alleles dependent on the sex of the transmitting parent was observed across the markers tested in our sample. Although some DNA variants showed stronger results for paternal transmission (DRD1-D1P.6), the association results were enhanced for maternal transmission for others (SNAP25-9806 and GNAL-7595).
The reasons for the discrepancies between the two studies are unclear. In most cases, the sample size and the number of informative transmissions for each marker allele tested both in the Irish and Toronto samples are similar, as well as the total number of maternal and paternal transmissions. Both studies used Diagnostical and Statistical Manual of Mental Disorders (DSM)-IV-based diagnosis procedure and the distribution of families between the DSM-IV ADHD combined, predominantly inattentive or predominantly hyperactive/impulsive subtypes was not strikingly different (Irish sample: 77-15-8%, respectively, vs Toronto sample: 62-24-14%, respectively). The boys:girls ratio is also similar (Toronto: 19% girls vs Irish: B12% girls 12 ). Ethnic differences cannot be excluded despite both samples being mostly composed of Caucasians. The sample in Hawi et al. is almost exclusively composed of Irish families while our sample is composed of a majority of families of European descent with a small proportion of 'other' or 'mixed' backgrounds, including Native-American, African, Chinese and Indian. Although differences in sample characteristics can explain the lack of replication between samples due to different linkage disequilibrium between markers, it is hard to explain how ethnicity could explain preferential parental transmission.
Beyond sample difference considerations, we have no explanation for the observed global overtransmission of paternal risk alleles in the study by Hawi et al. One point for consideration for these analyses is the use of a single marker for each gene and the choice of the 'risk' alleles. The identification of the true risk showed that some TPH2 markers displayed preferential paternal transmission whereas other markers showed a preferential transmission of the maternal alleles. Such observations are difficult to explain because a consistent pattern of parental transmission for multiple markers within a gene would generally be expected, although complex epigenetic regulation has been demonstrated for a few genes. The protein G s a subunit gene (GNAS), for example, uses four alternatively first exons with distinct tissue-specific promoters, two of which are expressed from the maternal chromosome and two from the paternal chromosome. Mutations inherited from the mother or the father give rise to overlapping but different phenotypes.
A possible concern for segregating based on parental gender is chance findings resulting from a low number of informative transmissions and, therefore, cautious interpretation is required. For several genes in Hawi et al.'s study, the overtransmission of the risk allele was also observed for the mothers, although to a lesser extent, and it is not clear if the pattern of preferential paternal transmission would stand in a larger sample. The examination of the 861G marker allele for the 5HTR1B gene clearly illustrates this point. With a subset of our sample from Toronto (115 families), we have previously reported evidence of biased transmission for paternal alleles (TDT P pat = 0.03; P mat = 0.49). With an updated sample (209 families), we no longer observe this (Table 1) . Similarly, according to a previous report 13 on a subset of the sample from Ireland, the 5HTR1B-861G allele showed stronger results for maternal transmissions (TDT: P pat = 0.052 vs P mat = 0.014; and HHRR: P pat = 0.01 vs P mat = 0.0035). Current pooled data analysis from six independent study samples supports an excess of paternal transmission for 5HTR1B-861G.
14 Variation in the sample characteristics could potentially explain the discrepancy between earlier and more recent results; however, chance findings observed in smaller samples are more likely.
Although a mechanism for the parent-of-origin effect observed by Hawi and colleagues has not been determined, one can hypothesize the possibility of a genomic imprinting mechanism, the silencing of one allele of a gene according to its parental origin.
In the majority of documented cases, imprinted genes exist in clusters in the genome; however, as noted by Hawi et al., none of the ADHD-associated genes of their study maps to any known imprinted genomic clusters. In addition, no biological evidence exists so far to support a parent-of-origin effect for these genes (e.g., expression level differences between paternal and maternal alleles). Furthermore, no molecular evidence exists to support the involvement of genomic imprinting in ADHD. That does not exclude the possibility that epigenetic factors are important in the regulation of isolated genes, which could also be temporal and/or tissue specific.
A neurodevelopmental etiology may be possible for ADHD, with imprinting effects affecting brain development leading to alterations in brain function influencing cognition and behavior. However, we believe it is premature to postulate a general pattern of preferential transmission of the paternal risk alleles of ADHD-associated genes, as this does not replicate in this independent sample and biological evidence for such a regulatory mechanism is not present at this point. Genetic variants contribute to the pathophysiology of eating disorders such as anorexia nervosa (AN) or bulimia nervosa (BN). However, the complex interplay between genetic and environmental factors in eating disorders is only incompletely understood. The regulation of gene expression is tightly controlled and well balanced in the organism by different mechanisms such as DNA methylation and histone modifications, which are known to be disturbed under several disease conditions. 1 Recent years have witnessed growing interest in epigenetic contributions to psychiatric disorders 2 and evidence for epigenetic alterations has been found in different psychiatric conditions, among them schizophrenia, 2 impaired stress-response 3 and depression. 4 Recently, we have reported genomic and gene-specific DNA hypermethylation in patients with alcohol dependence that was associated with hyperhomocysteinemia. 5 Hyperhomocysteinemia is known to be present also in patients suffering from AN. 6 The aim of this study was therefore to investigate possible alterations of genomic and gene-specific DNA methylation in the peripheral blood of a well-defined sample of females with eating disorders (HEaD-study). 6 This being a pilot-study, we examined the promoter methylation of two genes previously described to be regulated by DNA methylation, the alpha synuclein gene (SNCA) and the homocysteine-induced endoplasmatic reticulum protein (HERP) gene. ). All patients met Diagnostic and Statistical Manual of Mental Disorder (DSM) IV criteria for AN or BN. Diagnoses were established using the German version of the Structured Clinical Interview for DSM IV diagnoses. Written informed consent was obtained from all patients after the procedures had been fully explained to them. Fasting blood samples were collected on admission in ethylenediaminetetraacetic acidcontaining tubes. Homocysteine was determined by high-performance liquid chromatography using a Bio-Rad kit (BioRad, Hercules, CA, USA). Analysis of global and gene-specific DNA methylation and expression of the two genes investigated was performed as was recently described by us. 5, 7 Betweengroup comparisons were performed by t-tests or one-way analysis of variance (ANOVA), followed by all pairwise comparisons according to Bonferroni using SPSS for Windows 14.0 (SPSS Inc., Chicago, IL, USA).
We found a global DNA hypomethylation in patients with AN (47.7719.6%; ANOVA: F = 6.67; P = 0.002) when compared to controls (65.2710.5%; Bonferroni: P = 0.001). In addition, patients with AN showed a trend towards a lower global methylation compared to patients with BN (60.4722.3%; Bonferroni: P = 0.058). There was no difference between patients with BN and controls. After dividing the participants into those with normal homocysteine and those with hyperhomocysteinemia (X11.7 mmol/l), we found a significantly lower DNA methylation in the hyperhomocysteinemia group (50.8721.0% vs 62.2718.8%; t-test: T = À2.25; df = 33.4; P = 0.031). Patients suffering from both, AN and BN had significantly lower levels of SNCA mRNA (AN: DCT À2.2072.2; BN: DCT À3.2473.2; ANOVA: F = 11.7; P < 0.001) than controls (DCT À0.1271.2). Expression of HERP did not differ between groups. We found a significantly higher DNA methylation of the SNCA gene promoter in patients with AN (86.34711.4%; ANOVA: F = 3.38; P = 0.04) compared to controls (74.06723.8%; Bonferroni: P = 0.048). Patients with BN (82.83710.0%) did not differ from patients with AN and controls. No significant differences were found in the amount of DNA methylation in the HERP promoter.
To our knowledge, this is the first study reporting alterations of global and gene-specific DNA methylation in a sample of patients with eating disorders. We found a global DNA hypomethylation in females with AN, but not in those with BN. Elevated plasma homocysteine was associated with a reduced DNA methylation in peripheral blood cells, which is in line with several investigations in healthy probands. 8 
DNA methylation occurs by transfer of a methyl
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